IFLIT
BIO icon

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV’s Bio-Rad Laboratories Class A BIO Stock Holding History

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,000
Closed -$2.18M – 23
2024
Q2 		$2.18M Hold
8,000
– – 0.14% 17
2024
Q1 		$2.77M Buy
+8,000
New +$2.63M 0.19% 16

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's BIO Position: Q3 2024 in Review

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 8,000 shares — an estimated $2.18M sold.

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV first reported a position in BIO in Q1 2024 and held it in 2 quarters. The position peaked at $2.77M in Q1 2024. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV sold 8,000 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $2.18M.
  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and held it in 2 quarters.
  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's Bio-Rad Laboratories Class A position peaked at $2.77M in Q1 2024.
  • 438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's 13F filing for Q3 2024, filed 15 Oct 2024.